Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $191,159 | 45 | 59.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,576 | 24 | 24.9% |
| Travel and Lodging | $25,814 | 114 | 8.1% |
| Honoraria | $12,075 | 4 | 3.8% |
| Food and Beverage | $10,982 | 281 | 3.4% |
| Education | $379.93 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $131,960 | 101 | $0 (2019) |
| Astellas Pharma US Inc | $45,222 | 61 | $0 (2024) |
| PFIZER INC. | $20,076 | 34 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $17,947 | 36 | $0 (2021) |
| Boston Scientific Corporation | $16,890 | 19 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $15,688 | 29 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $15,512 | 26 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $12,718 | 25 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $11,520 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,502 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,682 | 10 | Astellas Pharma US Inc ($4,800) |
| 2023 | $13,392 | 10 | Intuitive Surgical, Inc. ($9,470) |
| 2022 | $2,972 | 6 | Astellas US LLC ($2,575) |
| 2021 | $2,475 | 11 | Astellas Pharma US Inc ($1,853) |
| 2020 | $19,609 | 23 | Boston Scientific Corporation ($11,865) |
| 2019 | $28,933 | 82 | Astellas Pharma US Inc ($8,007) |
| 2018 | $69,737 | 117 | GENZYME CORPORATION ($46,903) |
| 2017 | $170,186 | 217 | GENZYME CORPORATION ($80,364) |
All Payment Transactions
476 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $150.35 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/02/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $39.02 | General |
| Category: LithoVue_URO | ||||||
| 10/16/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $143.71 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/05/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $142.15 | General |
| 08/28/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: SURGERY | ||||||
| 07/04/2024 | Astellas US LLC | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Oncology | ||||||
| 05/19/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $40.83 | General |
| Category: Urology | ||||||
| 01/22/2024 | Astellas Pharma Europe Ltd | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $2,047.50 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Intuitive Surgical, Inc. | DA VINCI SP (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 09/20/2023 | Intuitive Surgical, Inc. | DA VINCI SP (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 08/19/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $511.22 | General |
| Category: SURGERY | ||||||
| 08/17/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $316.65 | General |
| Category: Urology | ||||||
| 08/16/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 07/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $502.44 | General |
| Category: SURGERY | ||||||
| 07/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $444.66 | General |
| Category: SURGERY | ||||||
| 07/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 04/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $1,545.00 | General |
| Category: Oncology | ||||||
| 01/01/2023 | Astellas Pharma Global Development | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $2,060.00 | General |
| Category: Oncology | ||||||
| 11/17/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $63.00 | General |
| 11/17/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $62.14 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/30/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $91.59 | General |
| Category: HORMONE THERAPY | ||||||
| 07/12/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $7.80 | General |
| 02/15/2022 | Astellas US LLC | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $2,575.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 438 | 478 | $288,656 | $53,109 |
| 2022 | 15 | 496 | 553 | $375,857 | $67,543 |
| 2021 | 13 | 540 | 577 | $282,587 | $60,843 |
| 2020 | 20 | 827 | 989 | $460,358 | $96,896 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 16 | 16 | $105,808 | $13,808 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 126 | $33,768 | $11,577 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 111 | $20,202 | $7,064 | 35.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 27 | 32 | $27,360 | $5,832 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 26 | $9,360 | $3,605 | 38.5% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 11 | 11 | $31,108 | $2,921 | 9.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,545 | $2,708 | 28.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 23 | 23 | $17,940 | $2,127 | 11.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,896 | $1,493 | 30.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 15 | 17 | $14,535 | $1,087 | 7.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 27 | 28 | $12,908 | $673.14 | 5.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 34 | $238.00 | $115.94 | 48.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 13 | 13 | $988.00 | $97.24 | 9.8% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 19 | 19 | $125,647 | $21,875 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 122 | $32,696 | $10,842 | 33.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 27 | 36 | $30,780 | $6,750 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 101 | $18,382 | $6,657 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 35 | $12,600 | $4,965 | 39.4% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 15 | 15 | $42,420 | $4,093 | 9.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $12,450 | $3,080 | 24.7% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 28 | 28 | $21,840 | $2,569 | 11.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,210 | $2,545 | 35.3% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2022 | 11 | 11 | $32,038 | $1,480 | 4.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 15 | 17 | $14,535 | $1,013 | 7.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 30 | 34 | $15,674 | $840.08 | 5.4% |
About Dr. Joseph Renzulli, MD
Dr. Joseph Renzulli, MD is a Urology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538108832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Renzulli, MD has received a total of $319,986 in payments from pharmaceutical and medical device companies, with $12,682 received in 2024. These payments were reported across 476 transactions from 45 companies. The most common payment nature is "Consulting Fee" ($191,159).
As a Medicare-enrolled provider, Renzulli has provided services to 2,301 Medicare beneficiaries, totaling 2,597 services with total Medicare billing of $278,391. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Providence, RI
- Active Since 06/05/2006
- Last Updated 03/17/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1538108832
Products in Payments
- JEVTANA (Drug) $119,357
- XTANDI (Drug) $43,538
- Xtandi (Drug) $22,280
- PROVENGE (Drug) $15,866
- ELIGARD (Drug) $15,512
- FIRMAGON (Drug) $12,703
- DISEASE STATE (Drug) $12,701
- Xofigo (Drug) $9,837
- DA VINCI SP (Device) $8,000
- Non-Covered (Drug) $6,637
- GENERAL - THERAPIES (Device) $5,096
- GENERAL THERAPIES (Device) $4,690
- IMFINZI (Drug) $4,296
- ENZALUTAMIDE (Drug) $3,793
- SPACEOAR (Device) $3,600
- Da Vinci Surgical System (Device) $3,520
- GENERAL - BPH (Device) $3,150
- LYNPARZA (Drug) $1,895
- Nubeqa (Drug) $1,474
- JELMYTO (Drug) $440.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Providence
Gyan Pareek, Md, MD
Urology — Payments: $159,818
Boris Gershman, M.d, M.D
Urology — Payments: $13,253
Dragan Golijanin, M.d, M.D
Urology — Payments: $12,359
Dr. Janice Santos Cortes, M.d, M.D
Urology — Payments: $12,283
Simone Thavaseelan
Urology — Payments: $11,331
Elias Hyams, Md, MD
Urology — Payments: $10,722